Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • financial results

    Tag: financial results

    You Searched For "financial results"
    Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore

    Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore

    Ruby Khatun Khatun9 Nov 2017 10:16 AM IST
    New Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
    GlaxoSmithKline Pharma Q2 net profit up 32 percent at Rs 130 cr

    GlaxoSmithKline Pharma Q2 net profit up 32 percent at Rs 130 cr

    Ruby Khatun Khatun28 Oct 2017 9:46 AM IST
    New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals reported a 31.83 percent rise in standalone net profit to Rs 130.32 crore for the second quarter...
    Abbott India Q1 net profit down 35 percent at Rs 48 crore

    Abbott India Q1 net profit down 35 percent at Rs 48 crore

    Ruby Khatun Khatun10 Aug 2017 9:16 AM IST
    New Delhi: Pharmaceuticals firm Abbott India on Tuesday reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended...
    Max India narrows balance sheet losses to Rs 46 cr in FY17

    Max India narrows balance sheet losses to Rs 46 cr in FY17

    Ruby Khatun Khatun30 May 2017 9:06 AM IST
    New Delhi: Max India has narrowed its consolidated losses by over 50 per cent to Rs 46.15 crore for fiscal ended March 2017, on better revenues from...
    Zydus Wellness Q4 net up 9 pc at Rs 30 cr

    Zydus Wellness Q4 net up 9 pc at Rs 30 cr

    Ruby Khatun Khatun29 May 2017 11:51 AM IST
    New Delhi: Zydus Wellness reported a 9.3 per cent increase in consolidated net profit at Rs 30.32 crore for the quarter ended March 31.The company had...
    Prev

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok